FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca’s new treatment for hypertension
In Phispers this week, the US Food and Drug Administration (FDA) approved AstraZeneca’s first-in-class treatment for hype...
Impressions : 2307
Chiesi, Arbor in US$ 2 bn gene therapy deal; Lilly to invest over US$ 1 bn in India; FDA okays Boehringer’s rare lung disease drug
In news this week, Italy’s Chiesi Group announced a deal worth up to US$ 2 billion with US-based Arbor Biotechnologies to...
Impressions : 3980
Novartis inks US$ 5.2 bn cardiology deal with China’s Argo, US$ 2 bn deal with Arrowhead; FDA okays first GLP-1 generic for weight
Novartis signed two deals this week — a US$ 5.2 billion cardiology deal with China’s Argo Biopharmaceuticals, and a...
Impressions : 1242
Sarepta lays off 500 employees post second death in Elevidys trial; FDA chief proposes lowering PDUFA fee
This week’s Phispers brings you updates on cell and gene therapies (CGTs). After the death of a second teenaged boy last ...
Impressions : 4492
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.